Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377702 · ClinicalTrials.gov registry record
Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 500,000
- Enrollment target
NCT00377702 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 500,000 participants.
The verdict
NCT00377702 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 500,000 participants
- Enrollment target
Study Summary
Cardiovascular disease (CVD) is one of the leading causes of death in the United States. Currently, there is little information about the lifetime risk of CVD among non-white ethnic groups. This study will analyze data from participants in several ongoing clinical studies to identify the lifetime risk for CVD among various ethnicities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500,000 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00377702
The ClinicalTrials.gov registry entry for NCT00377702 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00377702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00377702 about?
NCT00377702 is a clinical study titled "Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups". Cardiovascular disease (CVD) is one of the leading causes of death in the United States. Currently, there is little information about the lifetime risk of CVD among non-white ethnic groups. This study will analyze data from participants in several ongoing clinical studies to identify the lifetime ri...
What is the current status of trial NCT00377702?
This trial is currently completed. The enrollment target is 500,000 participants. The study started on 2006-07. Estimated completion is 2006-07.
Who is sponsoring clinical trial NCT00377702?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.